# Sarepta Therapeutics, Inc.: Form 8-K, filed Jul 16, 2025

- Company: [Sarepta Therapeutics, Inc.](/companies/srpt.md) (CIK 873303)
- Form: 8-K
- Filed: 2025-07-16
- Accepted by EDGAR: Jul 16, 2025, 16:11 ET
- Period: 2025-07-14
- Accession: 0000950170-25-096257
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/873303/000095017025096257/srpt-20250714.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/873303/000095017025096257/

## Items reported

- Item 2.02: Results of operations
- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/873303/000095017025096257/srpt-20250714.htm

Filed Jul 16, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-096257. Last ingested by Listed: Nov 5, 2026, 17:27 ET. No prices; not investment advice.